{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T17:55:29Z","timestamp":1777139729573,"version":"3.51.4"},"reference-count":10,"publisher":"Royal College of General Practitioners","issue":"620","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Gen Pract"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.3399\/bjgp14x677383","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T22:08:34Z","timestamp":1393366114000},"page":"120-121","source":"Crossref","is-referenced-by-count":2,"title":["Heartburn, Barrett\u2019s oesophagus and cancer: implications for primary care"],"prefix":"10.3399","volume":"64","author":[{"given":"Anthony","family":"Watson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"key":"2019052120243639000_64.620.120.1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.063685"},{"key":"2019052120243639000_64.620.120.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"2019052120243639000_64.620.120.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68932-0"},{"key":"2019052120243639000_64.620.120.4","unstructured":"NHS PCT Board Prescribing report (2010) Drugs for dyspepsia-prescribing guidelines and discussion points. NHS."},{"key":"2019052120243639000_64.620.120.5","unstructured":"Cancer Research UK How are Be Clear on Cancer campaigns evaluated? http:\/\/www.cancerresearchuk.org\/prod_consump\/groups\/cr_common\/@nre\/@hea\/documents\/generalcontent\/cr_113267.pdf (accessed 31 Jan 2014."},{"key":"2019052120243639000_64.620.120.6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/MEG.0b013e3283489dcf","article-title":"Barrett\u2019s, blood groups and progression to oesophageal cancer: is nitric oxide the link?","volume":"23","author":"Caygill","year":"2011","journal-title":"Eur J Gastro Hepatol"},{"key":"2019052120243639000_64.620.120.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.211_a.x"},{"key":"2019052120243639000_64.620.120.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2009.03316.x"},{"key":"2019052120243639000_64.620.120.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-006-9053-3"},{"key":"2019052120243639000_64.620.120.10","first-page":"1","article-title":"Guidelines for the diagnosis and management of Barrett\u2019s columnar-lined oesophagus","volume":"28","author":"Watson","year":"2005","journal-title":"Br Soc Gastroenterol Publ"}],"container-title":["British Journal of General Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgp14X677383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T19:36:49Z","timestamp":1645817809000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjgp.org\/lookup\/doi\/10.3399\/bjgp14X677383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":10,"journal-issue":{"issue":"620","published-online":{"date-parts":[[2014,2,24]]},"published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.3399\/bjgp14X677383"],"URL":"https:\/\/doi.org\/10.3399\/bjgp14x677383","relation":{},"ISSN":["0960-1643","1478-5242"],"issn-type":[{"value":"0960-1643","type":"print"},{"value":"1478-5242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]}}}